UK markets closed

Shield Therapeutics plc (STX.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
6.300.00 (0.00%)
At close: 04:35PM GMT
Currency in GBp

Valuation measures4

Market cap (intra-day) 38.07M
Enterprise value 35.66M
Trailing P/E 53.33
Forward P/E 65.36
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.81
Price/book (mrq)1.17
Enterprise value/revenue 11.62
Enterprise value/EBITDA -1.67

Trading information

Stock price history

Beta (5Y monthly) 1.18
52-week change 3-82.62%
S&P500 52-week change 3-7.75%
52-week high 337.00
52-week low 35.52
50-day moving average 36.98
200-day moving average 39.64

Share statistics

Avg vol (3-month) 32.27M
Avg vol (10-day) 3680.56k
Shares outstanding 5585.67M
Implied shares outstanding 6N/A
Float 8125.07M
% held by insiders 142.23%
% held by institutions 113.58%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-783.09%

Management effectiveness

Return on assets (ttm)-34.05%
Return on equity (ttm)-57.03%

Income statement

Revenue (ttm)3.07M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)322.20%
Gross profit (ttm)539k
EBITDA -22.9M
Net income avi to common (ttm)-23.84M
Diluted EPS (ttm)-8.70
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.4M
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.60
Book value per share (mrq)0.15

Cash flow statement

Operating cash flow (ttm)-17.46M
Levered free cash flow (ttm)-15.29M